A detailed history of Arvest Trust CO N A transactions in Pfizer Inc stock. As of the latest transaction made, Arvest Trust CO N A holds 485,907 shares of PFE stock, worth $13.3 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares
485,907
Previous 503,251 3.45%
Holding current value
$13.3 Million
Previous $14 Million 2.65%
% of portfolio
0.9%
Previous 0.88%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$25.26 - $29.6 $438,109 - $513,382
-17,344 Reduced 3.45%
485,907 $13.6 Million
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $21,669 - $24,884
-837 Reduced 0.17%
503,251 $14 Million
Q4 2023

Jan 24, 2024

BUY
$26.13 - $33.94 $4.71 Million - $6.12 Million
180,188 Added 55.63%
504,088 $14.5 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $90,910 - $106,265
-2,833 Reduced 0.87%
323,900 $10.7 Million
Q2 2023

Aug 15, 2023

SELL
$36.12 - $41.79 $294,305 - $340,504
-8,148 Reduced 2.43%
326,733 $12 Million
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $414,579 - $539,722
-10,525 Reduced 3.05%
334,881 $13.7 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $807,612 - $1.05 Million
-19,344 Reduced 5.3%
345,406 $17.7 Million
Q3 2022

Nov 07, 2022

BUY
$43.76 - $53.42 $1.09 Million - $1.33 Million
24,855 Added 7.31%
364,750 $16 Million
Q2 2022

Aug 11, 2022

SELL
$46.53 - $55.17 $287,881 - $341,336
-6,187 Reduced 1.79%
339,895 $17.8 Million
Q1 2022

May 04, 2022

SELL
$45.75 - $56.69 $61,122 - $75,737
-1,336 Reduced 0.38%
346,082 $17.9 Million
Q4 2021

Mar 08, 2022

BUY
$41.32 - $61.25 $14.4 Million - $21.3 Million
347,418 New
347,418 $20.5 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Arvest Trust CO N A Portfolio

Follow Arvest Trust CO N A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arvest Trust CO N A, based on Form 13F filings with the SEC.

News

Stay updated on Arvest Trust CO N A with notifications on news.